BioCentury
ARTICLE | Clinical News

AlzheimAlert urine test regulatory update

May 30, 2005 7:00 AM UTC

NYMX's PMA for a kit version of the AlzheimAlert urine test to diagnose Alzheimer's disease (AD) is expected to be reviewed in July by FDA's Medical Devices Advisory Committee. The PMA was accepted fo...